Core One (COOL.C) subsidiary begins development of psychedelic drug formulation for stroke treatment Post date June 21, 2021 Posted by Piers Eaton Posted in AKO001, Akome, Akome Biotech, Bioactive, Biotech, Core One Labs, Eaton, Health Science, Psychedelics, Scribes, stroke Comments 0